TrialEuropean urology2021

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study.

Patrick Cheung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.